is crsp stock a good buy

Tuesday, October 11, 2022 Edit

The stock has a market cap of 474 billion a price-to-earnings ratio of -739 and a beta of 187. Is it a good time to buy Crispr Therapeutics stock.

Crsp Crispr Therapeutics Ag Stock Overview U S Nasdaq Barron S

Over the past year the SP 500 has fallen -1695 while CRSP is lower by.

. This is not a recommendation however. Our overall hedge fund sentiment score. In this case its the cash flow growth thats.

There are currently 7 hold ratings and 9 buy ratings. As a hotly followed gene-editing company CRISPR Therapeutics CRSP 133 is on the bleeding edge of biotechnology. 15 Wall Street analysts covering NASDAQ.

CRSP has a Moderate Buy consensus rating based on 10 Buys and seven Holds assigned in the past three months. 16 Wall Street equities research analysts have issued buy hold and sell ratings for CRISPR Therapeutics in the last year. Its typically categorized as a valuation metric and is most often quoted as Cash Flow per Share and as a Price to Cash flow ratio.

CRSPs asset turnover comes in at 0441 -- ranking 101st of 681 Pharmaceutical Products stocks. CRISPR Therapeutics AG NASDAQCRSP is not the least popular stock in this group but hedge fund interest is still below average. CRSP stock is to Buy CRSP stock.

The target price for CRSP stock is 11273 based on the average of what a group of analyst think CRSP stock could be worth at a future date. Crispr Therapeutics AG CRSP stock has risen 2224 over the last 12 months and the average rating from Wall Street analysts is a Buy. At first glance stocks like CRISPR Therapeutics CRSP 133 would seem like the kind to avoid right now given the current uncertain state of equity markets.

The technical analysis gauge below displays real-time ratings for the timeframes you select. Is CRSP Stock a Good Buy. CRSP is lower by -086 from the previous closing price of 6082 on volume of 800285 shares.

CRSP has a Quality Grade of C ranking ahead of 7306 of graded US stocks. Out of 15 analysts 2 1333 are recommending CRSP as a Strong Buy 5 3333. Shares of CRSP opened at 6082 on Tuesday.

The business has a 50-day. Is CRSP Stock a Good Buy. Our overall hedge fund sentiment score for.

In a report released today Silvan Tuerkcan from JMP Securities maintained a Buy rating on Crispr Therapeutics AG CRSP - Research Report with a price target of 10000. The average CRSP price target of 10044. CRSP has a Moderate Buy consensus rating based on 10 Buys and seven Holds assigned in the past three months.

If youre willing to speculate yes. The consensus among. This is not a prediction by.

CRSP to investors the stock was. CRISPR Therapeutics AG NASDAQCRSP is not the least popular stock in this group but hedge fund interest is still below average. Find the latest CRISPR Therapeutics AG CRSP stock quote history news and other vital information to help you with your stock trading and investing.

Crsp Stock Price And Chart Nasdaq Crsp Tradingview